Business Standard
Thursday, Feb 16, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 

Bulk drug prices to fall after Olympics
Joe C Mathew / New Delhi Aug 11, 2008, 00:21 IST

With China expected to reopen several hundred bulk drug units after the Olympics, prices of some key bulk drugs, including penicillin and paracetamol, have crashed in the Indian market.

Industry sources said the price of an antibiotic like Erythromycin has fallen to Rs 7,500 a kg from Rs 10,500 a kg in less than a month and that of the broad-spectrum antibiotic Ciprofloxacin from Rs 1,700 to Rs 1,350 a kg.

 Click here for Cloud Computing
 
Prices of these and other drugs had risen in India after the Chinese government had closed its drug making units owing to environmental concerns over the last one year in the run-up to the Olympics.

Chinese firms are the largest suppliers of bulk drugs to India and control over 70 per cent of the Rs 15,000-crore annual market for imported bulk drugs.

The price rise has now started to reverse in anticipation that fresh Chinese supplies would start arriving in a few weeks once the closed units come back into production.

“Indian bulk drug importers were hoarding, but with demand turning slack, they have started clearing the stocks before cheaper Chinese imports start coming in,” Nipun Jain, managing partner, Pharmchem, said.

Prices have fallen even as the National Pharmaceutical Pricing Authority (NPPA) recently agreed to a long-pending request to raise retail prices of over 100 medicines to help the domestic drug industry tide over increasing raw material prices and exchange rate fluctuations.

A senior NPPA official said the price increase was based on the actual input cost data provided by the drug companies. He pointed out that the NPPA could not act against hoarding or artificial price increases.

“The price decrease cannot be seen as a trend. It just shows the instability of the market. The erratic supplies of raw materials from China had contributed to the price increase. The depreciation of the rupee against the dollar also made imports costlier for domestic bulk drug suppliers,” said D B Mody, chairman, International Trade Committee, Indian Drugs Manufacturers Association.

He claimed that even if prices of some bulk drugs fell, the situation still warranted a further increase in retail rates.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets off day's low
- Mentha oil continues to slide in futures trade
- NEWSALERT: SC seeks Centre's response on Radia tapes probe report
- Scam-hit telcos fight back for subscribers
- Prof Deepak Malhotra talks about building trust in negotiations
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- We live for our family. have you secured them?
- Office 365 for professionals and small businesses.
- Earn fuel worth Rs.2400 with Citi
- India's No. 1 Property Site. Click here to know more..
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Get 5% cashback on telephone bills with Citi
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Be part of it The World's Largest Aircraft.
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Leela parts ways with Kempinski
- Kanika Datta: The importance of being SRK
- Nestle: Food for thought
- Tailor-made but not good enough
- Tata Motors soars to record level as JLR propels profit
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
IRFC bond |  Antrix-Devas |  Rafale fighter |  Junglee |  IPL 5 |  Dhanlaxmi Bank |  Thomas Cook |  TCS |  Sarfaesi Act |  Vodafone |  Aakash tablet |  Sodexo |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us